Gastroenteropancreatic Neuroendocrine Tumours Cancer Pathway
The South Australian (SA) Gastroenteropancreatic Neuroendocrine (GEP NET) Tumours Pathway (PDF 2MB) provides recommendations based on current evidence for best practice, and consistent care in the management of persons diagnosed with Neuroendocrine Tumours (NETs) across South Australia. The SA GEP NET Pathway has been developed through a collaborative effort involving a wide range of health professionals, including NET specialist practitioners, generalist staff and consumers.
The Pathway adopts a multidisciplinary approach to the care of people affected by NETs with involvement of all relevant health professionals. The pathway sets out key requirements for the provision of optimal care which needs to be considered in the NET patient journey. However, it should be noted that not all patients will progress through each step of the pathway. This is a consequence of many factors, including disease outcomes, management decisions, and patient decisions.
The pathway is a statement of consensus based on current best practice, evidence and accepted approaches to cancer treatment and management.Recommendations should be followed subject to the health professional’s independent medical judgment and the patient’s preference in each individual case.